NCT00228839View on ClinicalTrials.gov

GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2006

Conditions

Graft vs Host Disease

Interventions

DRUG

Infliximab

Trial Locations (1)

30322

Children's Healthcare of Atlanta/Emory University, Atlanta

All Listed Sponsors

lead

Emory University

OTHER